California State Teachers Retirement System Sells 1,219 Shares of HCA Healthcare, Inc. (NYSE:HCA)

California State Teachers Retirement System lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 329,248 shares of the company’s stock after selling 1,219 shares during the quarter. California State Teachers Retirement System owned approximately 0.13% of HCA Healthcare worth $109,814,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in shares of HCA Healthcare by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC lifted its position in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after purchasing an additional 456,738 shares during the last quarter. Wellington Management Group LLP grew its stake in HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after purchasing an additional 170,560 shares during the period. Royal Bank of Canada lifted its holdings in shares of HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares in the last quarter. Finally, Capital World Investors raised its stake in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the sale, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The disclosure for this sale can be found here. Over the last quarter, insiders sold 21,241 shares of company stock valued at $7,107,861. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

NYSE HCA traded up $1.70 during mid-day trading on Wednesday, reaching $363.05. 1,243,361 shares of the stock were exchanged, compared to its average volume of 1,160,018. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The business’s 50 day moving average is $331.60 and its 200-day moving average is $323.71. The company has a market capitalization of $95.09 billion, a P/E ratio of 18.10, a P/E/G ratio of 1.37 and a beta of 1.68. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $366.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.29 earnings per share. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.73%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Analyst Ratings Changes

Several research analysts recently weighed in on HCA shares. Cantor Fitzgerald restated an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a research note on Wednesday, July 24th. Wells Fargo & Company lifted their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft boosted their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Finally, TD Cowen decreased their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $344.06.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.